Kewaunee Scientific (NASDAQ:KEQU) Receives "Hold (C+)" Rating from Weiss Ratings

Key Points

• Kewaunee Scientific's stock has received a reaffirmed "Hold (C+)" rating from Weiss Ratings and an upgraded "Buy" rating from Wall Street Zen.
• The company reported $1.10 earnings per share (EPS) for the last quarter, with a revenue of $71.10 million and a return on equity of 25.65%.
• Insiders, including VP Elizabeth D. Phillips, have sold a total of 15,880 shares of company stock worth approximately $736,961 in the last three months.

Kewaunee Scientific (NASDAQ:KEQU - Get Free Report)'s stock had its "hold (c+)" rating reaffirmed by equities research analysts at Weiss Ratings in a research report issued to clients and investors on Wednesday,Weiss Ratings reports.

Separately, Wall Street Zen raised shares of Kewaunee Scientific from a "hold" rating to a "buy" rating in a research note on Saturday, July 5th. One research analyst has rated the stock with a Hold rating, According to data from MarketBeat.com, the stock presently has an average rating of "Hold".

Kewaunee Scientific Price Performance

Shares of Kewaunee Scientific stock opened at $43.83 on Wednesday. The firm has a market capitalization of $125.62 million, a PE ratio of 10.61 and a beta of 0.68. The company has a current ratio of 2.32, a quick ratio of 1.63 and a debt-to-equity ratio of 0.88. Kewaunee Scientific has a 12 month low of $30.33 and a 12 month high of $71.33. The business's 50-day moving average price is $50.83 and its 200-day moving average price is $45.14.

Kewaunee Scientific (NASDAQ:KEQU - Get Free Report) last issued its earnings results on Wednesday, September 10th. The technology company reported $1.10 earnings per share (EPS) for the quarter. Kewaunee Scientific had a return on equity of 25.65% and a net margin of 4.68%.The business had revenue of $71.10 million during the quarter.

Insider Buying and Selling

In other Kewaunee Scientific news, VP Elizabeth D. Phillips sold 6,880 shares of the business's stock in a transaction dated Thursday, October 2nd. The shares were sold at an average price of $43.20, for a total value of $297,216.00. Following the transaction, the vice president owned 8,248 shares in the company, valued at approximately $356,313.60. The trade was a 45.48% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CFO Donald T. Gardner III sold 3,000 shares of the stock in a transaction dated Thursday, July 24th. The stock was sold at an average price of $58.59, for a total transaction of $175,770.00. Following the sale, the chief financial officer owned 14,564 shares of the company's stock, valued at approximately $853,304.76. This represents a 17.08% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 15,880 shares of company stock valued at $736,961 over the last three months. 13.30% of the stock is owned by company insiders.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently bought and sold shares of the business. Mink Brook Asset Management LLC bought a new stake in shares of Kewaunee Scientific in the 2nd quarter worth approximately $370,000. Raymond James Financial Inc. purchased a new stake in Kewaunee Scientific in the second quarter worth $60,000. First Trust Advisors LP boosted its holdings in Kewaunee Scientific by 3.4% in the second quarter. First Trust Advisors LP now owns 6,726 shares of the technology company's stock valued at $395,000 after acquiring an additional 222 shares in the last quarter. Minerva Advisors LLC increased its position in Kewaunee Scientific by 5.0% during the 2nd quarter. Minerva Advisors LLC now owns 77,442 shares of the technology company's stock valued at $4,501,000 after purchasing an additional 3,677 shares during the period. Finally, De Lisle Partners LLP raised its holdings in Kewaunee Scientific by 6.7% in the 2nd quarter. De Lisle Partners LLP now owns 47,977 shares of the technology company's stock worth $2,811,000 after purchasing an additional 3,029 shares in the last quarter. Institutional investors own 32.69% of the company's stock.

Kewaunee Scientific Company Profile

Kewaunee Scientific Corporation designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products. The company operates through two segments, Domestic and International. Its products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, and epoxy resin work surfaces and sinks.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.